Europe Travel Vaccines Market Analysis / Forecast Report 2021-2022 and 2028 with Abbott, Dynavax Technologies, Emergent BioSolutions, GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi and Valneva –

DUBLIN–(BUSINESS WIRE)–The report “Europe Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product and Application” has been added to from offer.

Europe Travel Vaccines Market is expected to grow from US$995.47 Million in 2021 to US$1,885.56 Million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.

Hepatitis, HIV/AIDS, human papilloma virus (HPV), meningococcal disease, typhoid and yellow fever are among the various chronic diseases detected in the region.

Similarly, in 2021, the Centers for Disease Control and Prevention (CDC) launched the Global Immunization Strategic Framework 2021-2030. The framework provides a vaccination plan for vaccine-preventable diseases (VPDs), such as hepatitis A and B. Additionally, there are different vaccination routines for travelers suggested by WHO to prevent the spread of diseases deadly infections.

The vaccine routine includes routine vaccines to review before travelling, vaccines for certain destinations and vaccines required by certain countries. In most cases, booster doses of routine vaccines are needed if people have not followed the regular schedule. Such initiatives by WHO and CDC are enhancing the demand for vaccines, thereby driving the growth of its market.

On the other hand, the COVID-19 epidemic has threatened public health. Various emergency actions have been launched during the pandemic, of which the COVAX initiative has been aggressively embraced. Vaccination against COVID-19 was mandatory for people around the world. Governments in each region have made vaccinations mandatory for people traveling within and outside the countries. The COVID-19 pandemic has contributed significantly to travel vaccines.

With new features and technologies, vendors can attract new customers and expand their footprint in emerging markets. This factor is likely to drive the travel vaccine market in Europe.

Europe Travel Vaccines Market Segmentation

  • In 2021, the others segment held the largest market share.

  • In 2021, the outbound travel segment held the largest market share.

Key Market Dynamics

Market factors

  • Significant increase in travel and tourism

  • Growing incidence of infectious diseases

Market constraints

  • High cost of travel vaccines

Market opportunities

  • Vaccine Awareness

Future trends

  • Significant demand for vaccines

Company Profiles

  • Abbott

  • Dynavax Technologies

  • Emergent BioSolutions Inc.

  • GlaxoSmithKline plc

  • Merck & Co., Inc.

  • Novartis AG

  • Pfizer Inc.

  • Sanofi

  • Valneva SE

For more information about this report visit

Comments are closed.